Chern Hsiang Choy, Richard P Steeds, Jennifer Pinney, Shanat Baig, Lauren Turvey-Haigh, Yasmin Wahid, Helen Cox, Alex Zaphiriou, Venkataramanan Srinivasan, David Wilson, John Fryearson, Mubarak Ahamed, Sern Lim, Colin Chue, Guy Pratt, Marianna Fontana, Julian D Gillmore, William E Moody
There has been an exponential increase in the diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CA). In response, the Midlands Amyloidosis Service was launched with the aim of providing patients with a timely diagnosis, remote expertise from the National Amyloidosis Centre and access to emerging transthyretin (TTR)-directed therapies. This was a descriptive study of a pilot hub-and-spoke model of delivering specialist amyloidosis care. Patients with suspected amyloidosis were referred from the wider Midlands region, and seen in a consultant-led multidisciplinary clinic...
January 19, 2024: Clinical Medicine: Journal of the Royal College of Physicians of London